Introduction
Injection of depot pentagastrin into pregnant bitches during the second half of pregnancy has been shown to produce congenital hypertrophic pyloric stenosis (CHPS) in their pups (Dodge, 1970; Dodge and Karim, 1976) . Controversy remains, however, as to whether gastrin either from mother or infant has a role in the pathogenesis of CHPS in man. Raised serum gastrin levels have been found in infants with CHPS before pyloromyotomy (Spitz and Zail, 1976; Bleicher et al., 1978) . In other studies pre-pyloromyotomy serum gastrin levels in infants with CHPS did not differ significantly from those in control infants (Rogers et al., 1975; Moazam et al., 1978; Hambourg et al, 1979; Grodiowski et al., 1980) . It is not known whether maternal gastrin can cross the placenta (Werlin, Grand and Drum, 1978 ).
Werlin and his co-workers showed however that the cord blood gastrin levels in 40 infants with CHPS did not differ from controls, nor was there any difference between the serum gastrin levels of the mothers of each group. Furthermore the mean cord blood gastrin levels of both the patient and control infants were significantly higher than the mean maternal levels.
We report the birth of a normal infant to a mother with the Zollinger-Ellison syndrome. The cord blood gastrin was very high, but the infant did not develop hypertrophic pyloric stenosis.
Case report
In 1971 (Bruchner, Snow and Tonkalerud, 1970) . It is not known whether maternal gastrin can cross the placenta in humans (Werlin et al., 1978) but the presence of high cord blood serum gastrin in this case strongly suggests that maternal gastrin does cross the placenta.
The cause of CHPS is unknown but it is thought that many genetic and environmental factors, including the important modifying effect of gender, operate together to produce the condition (Dodge, 1973) . Since injections of depot pentagastrin given to pregnant bitches in the second half of pregnancy have been shown to produce pyloric stenosis in 28% of pups (Dodge and Karim, 1976) , there has been controversy as to whether raised blood gastrin either in utero or post-natally may be one such environmental factor in man. The findings of Werlin that infants with pyloric stenosis do not have elevated cord blood serum gastrin makes the possibility that an elevated serum gastrin concentration at the time of delivery is implicated in the pathogenesis unlikely. The failure of the infant described above to develop CHPS could be due to the lack of other environmental and genetic factors such as maleness. Nonetheless the absence of CHPS in this child is further evidence against the hypothesis that intrauterine exposure to a high dose of gastrin is an important causative factor in the development of the condition in man. 
